[Scalp cooling in patients at risk of chemotherapy-induced alopecia]

Perelli L, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A.
Record ID 32018001496
Spanish
Original Title: Enfriamiento del cuero cabelludo en pacientes con riesgo de alopecia inducida por quimioterapia
Authors' recomendations: CONCLUSIONS Moderate-quality evidence suggests that scalp cooling is an effective measure for preventing alopecia induced by chemotherapy agents in solid tumor treatment and reduces the need for wearing wigs in these patients. No studies comparing automated versus manual scalp cooling methods have been found. Some private and public health sponsors from high-income countries consulted cover scalp cooling in patients with solid tumors under chemotherapy, at risk of alopecia, without specifying any of the methods currently available. Some of the Clinical Practice Guidelines consulted on treatment of women with breast cancer and chemotherapy administration recommend scalp cooling as prevention for chemotherapy-induced alopecia. No economic evaluations published in Argentina have been found; therefore the cost-effectiveness and budgetary impact of this technology is unknown.
Details
Project Status: Completed
Year Published: 2018
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Alopecia
  • Neoplasms
  • Chemotherapy, Adjuvant
  • Hypothermia, Induced
  • Scalp
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.